Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05631509

Genetic Study of Obstructive Azoospermia

Status
Recruiting
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Academic / Other
Sex
Male
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

In 1% of men with infertility, obstructive azoospermia (OA) may occur in congenital absence of the vas (CAVD) or idiopathic obstructive azoospermia . Many studies have shown that the pathogenic genes of OA are CFTR and ADGRG2 genes, and the inheritance mode is autosomal recessive. Although the conventional assisted reproductive technology(PESA/TESA) can help these patients have children, male patients who carry mutations of the disease-causing genes (CFTR and ADGRG2) will also pass on their mutations to the next generation, which will increase the risk of male offspring infertility. Therefore, genetic detection of CFTR and ADGRG2 genes is very necessary for CAVD patients before assisted reproduction. Genetic diagnosis plays a key role in preventing the disease to the offspring.

Conditions

Timeline

Start date
2021-07-01
Primary completion
2025-12-31
Completion
2025-12-31
First posted
2022-11-30
Last updated
2024-05-08

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05631509. Inclusion in this directory is not an endorsement.